Zoetis Inc. (ZTS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EST
After hours:
| Previous close | 223.33 |
| Open | 222.89 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 900 |
| Day's range | 220.99 - 225.00 |
| 52-week range | 141.41 - 228.89 |
| Volume | |
| Avg. volume | 1,526,504 |
| Market cap | 105.493B |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | 53.74 |
| EPS (TTM) | 4.15 |
| Earnings date | 14 Feb 2022 - 18 Feb 2022 |
| Forward dividend & yield | 1.00 (0.45%) |
| Ex-dividend date | 28 Oct 2021 |
| 1y target est | 238.83 |
- Business Wire
Zoetis Named One of Newsweek’s Most Responsible Companies for 2022
PARSIPPANY, N.J., December 02, 2021--Zoetis has been named to Newsweek Magazine's America's Most Responsible Companies 2022 list.
- Simply Wall St.
Zoetis (NYSE:ZTS) jumps 4.4% this week, though earnings growth is still tracking behind five-year shareholder returns
Buying shares in the best businesses can build meaningful wealth for you and your family. And highest quality companies...
- Motley Fool
Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows
Johnson & Johnson (NYSE: JNJ) announced last week that it plans to spin off its consumer healthcare business into a separate publicly traded entity. J&J said that this move will unlock shareholder value and accelerate growth. Pfizer (NYSE: PFE) and GlaxoSmithKline established a joint venture for their consumer health units.
© 2021 Yahoo. All rights reserved.
